You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / MANGALAM DRUGS & ORGANICS LTD

MANGALAM DRUGS & ORGANICS LTD Analysis

Returns | 1W : 2.1% , 1M : -2.3%,1Y : 278.6%
BOM : 532637     NSE : MANGALAM    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : Average [>25% and <50%]
Jan 22,2021
Price(EOD): Rs. 129.75
This is the End-of-Day (EOD) Stock Price updated daily by 10 pm IST.
MarketCap: Rs. 205.01 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
MANGALAM DRUGS & ORGANICS LTD 2.1% -2.3% 278.6%
SUN PHARMACEUTICAL INDUSTRIES LTD -1.1% 0.1% 30.6%
DR REDDYS LABORATORIES LTD -0.4% -3.6% 65.1%
DIVIS LABORATORIES LTD -0.6% -3.9% 94.4%
CIPLA LTD 0.8% -2% 72.3%
BIOCON LTD -12.3% -18.6% 51%
AUROBINDO PHARMA LTD 0.8% 3.8% 81.4%
LUPIN LTD 1.6% 12.1% 44.7%
TORRENT PHARMACEUTICALS LTD 2.1% -3.9% 37%

FUNDAMENTAL ANALYSIS OF MANGALAM DRUGS & ORGANICS LTD

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than MANGALAM DRUGS & ORGANICS LTDPremium

As on 22-Jan-2021, the Fundamentals of MANGALAM DRUGS & ORGANICS LTD are Poor and hence it's not good for long term investment ! See Financial Performance of MANGALAM DRUGS & ORGANICS LTD. Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!


VALUATION OF MANGALAM DRUGS & ORGANICS LTD

 
Valuation Score
RatioValue
P/E
P/B
P/S
24.9
P/E Calculated based on EPS of 5.21
[ Mar2020 - Standalone Results ]

1.98
P/B Calculated based on Book Value of 65.67
[ Mar2020 - Standalone Results ]

0.64
P/S Calculated based on Revenues of 320.953 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than MANGALAM DRUGS & ORGANICS LTDPremium

As on 22-Jan-2021, MANGALAM DRUGS & ORGANICS LTD is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!


INTRINSIC VALUE OF MANGALAM DRUGS & ORGANICS LTD

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
56%
-5%
-6%

As on 22-Jan-2021, the Intrinsic Value of MANGALAM DRUGS & ORGANICS LTD is Rs. 136.08 determined based on Median of the 3 historical models.
Fair Value based on Median EV / EBIDTA Model : Rs. 82.92
Fair Value based on Median EV / Sales Model : Rs. 136.08
Fair Value based on Median Price / Sales Model : Rs. 137.81
Median Fair Value of MANGALAM DRUGS & ORGANICS LTD : Rs. 136.08

As on 22-Jan-2021, MANGALAM DRUGS & ORGANICS LTD is trading at a Discount of -5% based on the Median Intrinsic Value!


SHARE PRICE MOMENTUM OF MANGALAM DRUGS & ORGANICS LTD

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.48
0.66
0.66
0.6
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
33.57 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
-6.38%
28.25%
33.64%
33.63%
44.23%
197.58%
1078.51%
1272.03%
QtrlyTrend
6
Latest Qtr: Sep2020




Open Demat Account & Start Investing
    Affiliate Links

Disclosure

The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z